|
|
|
|
 |
|
|
|
|
|
| Accurate detection and differentiation between different viruses responsible for respiratory infections is often the first step to proper treatment. Multiplex testing assays allow laboratories to test for multiple infectious disease targets in a single reaction. Explore our featured resources below to discover more. |
|
|
|
Prepare your lab for flu season with multiplex PCR
|
| Speakers: |
Peter Friebe, Ph.D. Senior Manager, Clinical Application and Marketing Support, Thermo Fisher Scientific and Lauren Miller Scientist, Clinical Applications / Marketing Support, Thermo Fisher Scientific |
| Date: |
3 November 2022 |
| Time: |
2:00 p.m. GMT, 3:00 p.m. CET |
Register now »
|
|
|
|
|
Free learning guide: respiratory tract infections
This learning guide presents comprehensive but carefully curated information on the most common viral, bacterial, fungal, and parasitic RTIs.
Download now » |
|
|
|
Technical note: Five respiratory viruses. One TaqPath panel.
Our robust multiplex assays, combined with high‑quality PCR systems, are designed to enable the detection of five respiratory viruses using the same patient sample.
Access now » |
|
|
| Benefits of molecular testing |
|
Why test for respiratory pathogens?
Early, accurate detection and differentiation is the first step towards understanding the cause of infection and determining next steps.
Discover more »
|
|
|
|
|
 |
Influenza: a global health threat in COVID‑19's shadows
Read blog » |
|
 |
The need to expand your molecular respiratory testing
Read blog » |
|
|
|
|
|
|
|
